Text information

---

JORF No. 8 of 10 January 2002 Page 593
Text No. 14


DECISION
Decision of 21 December 2001 deleting the generic group directory referred to in Article R. 5143-8 of the Public Health Code

NOR: MESM0124474S ELI: http://www.legifrance.gouv.fr/eli/decision/2001/12/21/MESM0124474S/jo/texte

The Director General of the French Health Products Safety Agency,
In view of the Public Health Code, and in particular Articles L. 5121-1 and R. 5143-8 ;
In view of the decision of 25 October 2001 listing the generic groups referred to in Article R. 5143-8 of the Public Health Code;
In view of the decision of the Council of State dated 26 November 2001 annulling Market authorization for the pharmaceutical specialty Troxérutine Merck 3.5 g,
Decides:

Item 1

Radiated from generic group directory Merck specialty 3.5 g, powder for suspension Drug-dose drinkable, Merck labs Generic, 348 947: box of 10 sachets.
The generic group Troxérutine 3 500 mg, Rhéoflux 3 500 mg, powder for oral suspension in sachet, Veinamitol 3 500 mg, powder for oral suspension Of the generic group directory, as set out in the above decision of 25 October 2001, is amended accordingly.

Article 2

This decision will be published in the Official Journal of the French Republic.

Done at Paris, December 21, 2001.

P. Duneton

---

Download the document in RTF (weight < 1MB) Facsimile (format: pdf, weight < 3.5 MB) Download document to RDF (format: rdf, weight < 1MB)